Home / Facilities / 3004404787

Taisho Pharmaceutical (M) SDN BHD — FDA Facility Profile

FEI 3004404787

Taisho Pharmaceutical (M) SDN BHD is an FDA-inspected facility (FEI 3004404787) located in Bandar Baru Bangi, MY. RegDataLab tracks 1 FDA inspection at this facility.

Reviewing Taisho Pharmaceutical (M) SDN BHD as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Taisho Pharmaceutical (M) SDN BHD yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Nov 2, 2023: Voluntary Action Indicated (VAI)
Inspections on record
1 (1 VAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 2, 2023Voluntary Action Indicated (VAI)Components - representative samples (21 CFR 111.155(c)(1))
Specifications - component identity (21 CFR 111.70(b)(1))
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
and 1 more

Facility details

Company
Taisho Pharmaceutical (M) SDN BHD
Location
Bandar Baru Bangi (MY)
Source
inspections

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.